BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3337451)

  • 21. Lung function in infants with cystic fibrosis diagnosed by newborn screening.
    Linnane BM; Hall GL; Nolan G; Brennan S; Stick SM; Sly PD; Robertson CF; Robinson PJ; Franklin PJ; Turner SW; Ranganathan SC;
    Am J Respir Crit Care Med; 2008 Dec; 178(12):1238-44. PubMed ID: 18787217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchodilators increase airway instability in cystic fibrosis.
    Zach MS; Oberwaldner B; Forche G; Polgar G
    Am Rev Respir Dis; 1985 Apr; 131(4):537-43. PubMed ID: 3994149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchodilator responsiveness in wheezy infants predicts continued early childhood respiratory morbidity.
    Shavit S; Cohen S; Goldman A; Ben-Dov L; Avital A; Springer C; Hevroni A
    J Asthma; 2016 Sep; 53(7):707-13. PubMed ID: 27042758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of respiratory inductance plethysmography with thoracoabdominal compression in bronchial challenges in infants and young children.
    Springer C; Godfrey S; Vilozni D; Bar-Yishay E; Noviski N; Avital A
    Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):665-9. PubMed ID: 8810603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infants with cystic fibrosis: pulmonary function at diagnosis.
    Tepper RS; Hiatt P; Eigen H; Scott P; Grosfeld J; Cohen M
    Pediatr Pulmonol; 1988; 5(1):15-8. PubMed ID: 3174271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total respiratory system compliance in asymptomatic infants with cystic fibrosis.
    Tepper RS; Hiatt PW; Eigen H; Smith J
    Am Rev Respir Dis; 1987 May; 135(5):1075-9. PubMed ID: 3579006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial expiratory flow-volume curves in infancy: technical aspects.
    Silverman M; Prendiville A; Green S
    Bull Eur Physiopathol Respir; 1986; 22(3):257-62. PubMed ID: 3730643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the squeeze technique and transcutaneous oxygen tension for measuring the response to bronchial challenge in normal and wheezy infants.
    Clarke JR; Reese A; Silverman M
    Pediatr Pulmonol; 1993 Apr; 15(4):244-50. PubMed ID: 8469578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial forced expiratory flow-volume curves in young children during ketamine anesthesia.
    Shulman DL; Bar-Yishay E; Beardsmore CS; Beilin B; Godfrey S
    J Appl Physiol (1985); 1987 Jul; 63(1):44-50. PubMed ID: 3624146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis.
    Peterson-Carmichael SL; Harris WT; Goel R; Noah TL; Johnson R; Leigh MW; Davis SD
    Pediatr Pulmonol; 2009 May; 44(5):503-11. PubMed ID: 19382221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of salbutamol on histamine induced bronchoconstriction in healthy infants.
    Henderson AJ; Young S; Stick SM; Landau LI; LeSouëf PN
    Thorax; 1993 Apr; 48(4):317-23. PubMed ID: 8511728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung function and bronchial challenges in infants: repeatability of histamine and comparison with methacholine challenges.
    Stick SM; Turner DJ; LeSouëf PN
    Pediatr Pulmonol; 1993 Sep; 16(3):177-83. PubMed ID: 8309743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis.
    Houstĕk J; Zapletal A; Samánek M; Vávrová V
    Czech Med; 1979; 2(1-2):1-10. PubMed ID: 527420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis.
    Aurora P; Bush A; Gustafsson P; Oliver C; Wallis C; Price J; Stroobant J; Carr S; Stocks J;
    Am J Respir Crit Care Med; 2005 Feb; 171(3):249-56. PubMed ID: 15516530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic growth and development of the lung during the first year of life.
    Tepper RS; Morgan WJ; Cota K; Wright A; Taussig LM
    Am Rev Respir Dis; 1986 Sep; 134(3):513-9. PubMed ID: 3752707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis.
    Macfarlane PI; Heaf D
    Pediatr Pulmonol; 1990; 8(1):4-11. PubMed ID: 2405343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilator responsiveness in normal infants and young children.
    Goldstein AB; Castile RG; Davis SD; Filbrun DA; Flucke RL; McCoy KS; Tepper RS
    Am J Respir Crit Care Med; 2001 Aug; 164(3):447-54. PubMed ID: 11500348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral airway involvement in CF and asthma compared by inert gas washout.
    Gustafsson PM
    Pediatr Pulmonol; 2007 Feb; 42(2):168-76. PubMed ID: 17186546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infants with upper respiratory illnesses have significant reductions in maximal expiratory flow.
    Martinez FD; Taussig LM; Morgan WJ
    Pediatr Pulmonol; 1990; 9(2):91-5. PubMed ID: 2399052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.